“Having the opportunity to be part of a team bringing innovative treatments to cancer patients continues to motivate me time and time again. The close interaction with leaders in the field is an honor and a pleasure.”
- Julia Schüler, DVM, PhD
Julia Schüeler serves as the Therapeutic Area Lead Oncology at Charles River. As a tumor biologist, Julia is an expert in preclinical oncology drug testing platforms. She leads a multidisciplinary team supporting the expansion of our current portfolio of preclinical PDX models (pediatric and adult tumor models) and implementing new technologies such as small animal imaging, multiplex omics-analyses, and image analysis workflows.
Connect with Dr. Schüler on LinkedIn
Featured Resource
Podcasts
- From Tumor to Treatment: How PDX Models are Powering Cancer Breakthroughs (Sounds of Science)
- CRISPR's Rogue Tendencies (Sounds of Science)
Articles
- What Was Trending at the AACR Annual Meeting 2024? (Eureka Blog)
- What's Hot in 2020: Oncology (Eureka Blog)
- Knock-Out Punch in Breast Cancer Mouse Study (Eureka Blog)
- Translating Science into Survival (Eureka Blog)
- The Human Parts of Mouse Models (Contract Pharma)
Webinars
- Data Insights: Selecting the Optimal Platform for Oncology Drug Development
- Advance Your Oncology and Immunology Research with Next-Generation Mouse Models
- Selecting the Optimal In Vivo Platform for Oncology Drug Development
- Ensure Your Oncology Program is FDA-Compliant Under the Updated RACE Act Legislation
- Case Study Video Series: Driving CAR-T Forward
- A Humanized Lung Cancer In Vivo Platform for Immunotherapy Research